Navigation Links
Omeros Corporation Reports Fourth Quarter and Year-End 2012 Financial Results
Date:3/18/2013

r ended December 31, 2012, Omeros reported a net loss of $7.7 million, or $0.30 per share, compared to a net loss of $10.2 million, or $0.46 per share, for the same period in 2011. For the year ended December 31, 2012, Omeros reported a net loss of $38.4 million, or $1.59 per share, compared to a net loss of $28.5 million, or $1.29 per share, in 2011.

At December 31, 2012, Omeros had cash and cash equivalents and short-term investments of $22.4 million. Omeros expects that, taking into account its at-the-market equity facility with MLV & Co. LLC and its committed equity line financing facility with Azimuth Opportunity Ltd., it has sufficient resources to fund anticipated operating expenses, capital expenditures and note payments for at least the next 12 months.

"In 2012, our lead program, OMS302 for lens replacement surgery, completed two successful Phase 3 clinical trials – we are preparing to submit the NDA and MAA in the coming months and are planning the drug's commercial launch in 2014," said Gregory A. Demopulos , M.D., chairman and chief executive officer of Omeros. "OMS103HP, our product for arthroscopic surgery, delivered statistically significant and clinically important pain reduction in a Phase 3 clinical trial and will enter its next pivotal Phase 3 trial later this year. In addition, we are planning to report data soon from our PDE10 Phase 1 program for schizophrenia and cognitive disorders, and our MASP-2 and PDE7 programs are on track to enter the clinic this year. All of these programs, together with our GPCR program and the rest of our pipeline, provide us multiple opportunities for success in 2013."

Fourth Quarter Highlights

  • Announced the identification of compounds that interact selectively with four additional orphan G protein-coupled receptors (GPCRs), bringing the total number of orphans GPCRs unlocked by Omeros to 46, representing approximately 60 percent of the Class A o
    '/>"/>

  • SOURCE Omeros Corporation
    Copyright©2012 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related biology technology :

    1. Omeros Announces Enrollment in Phase 1 Clinical Trial Evaluating OMS824
    2. Omeros to Present at the 19th Annual Newsmakers in the Biotech Industry Conference
    3. Omeros Has Now Unlocked Over Half of the Class A Orphan GPCRs
    4. Omeros Announces it has Unlocked 30 Percent of Class A Orphan GPCRs
    5. Omeros Announces It Has Unlocked Over 20 Percent of Class A Orphan GPCRs
    6. New Opportunity: The Biomedical Innovations of Tomorrow - Research Report on PhotoMedex, Axiall Corp, Varian Medical Systems, Volcano Corporation and Navidea Biopharmaceuticals
    7. China Cord Blood Corporation Reports Financial Results for the Third Quarter and First Nine Months of Fiscal 2013
    8. Testing Positive for Stability & Growth - Research Report on CombiMatrix Corporation, Cepheid, PerkinElmer, Inc., Life Technologies Corp. and Laboratory Corp. of America Holdings
    9. R&D, Innovation Key to Success - Research Report on Varian Medical Systems, Inc., Boston Scientific Corporation, Stryker Corporation, St. Jude Medical, Inc., and Thermo Fischer Scientific Inc.
    10. FibeRio® Technology Corporation Announces Strategic Investment Financing Led by SABIC and Aster Capital
    11. Celsion Corporation Announces $15 Million Registered Direct Offering
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:7/29/2015)... , July 30, 2015 ... results for the second quarter of 2015. CEO ... results and its performance in different businesses. ... http://www.eurobusinessmedia.com/ceo-direct/sanofi/sanofi-h1-2015-results-interview-with-ceo-olivier-brandicourt?utm_source=ceo-direct&utm_medium=wire Topics covered ... results - Performance drivers ...
    (Date:7/29/2015)... , July 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: ... the Company,s Chief Financial Officer has resigned.  The Company ... Financial Officer who retired in December 2014, as full ... a permanent successor.     Andy Ashworth ... and ensure a smooth transition.  Andy was the Company,s ...
    (Date:7/29/2015)... ... July 29, 2015 , ... Brady (NYSE:BRC), a global ... Guide . To align chemical container labeling with OSHA’s updated Hazard Communication (HazCom) ... components, an example of an accurate label, and pictogram uses and meanings. , ...
    (Date:7/29/2015)... ... July 29, 2015 , ... The third Medical Innovation Impact Index (MI3) Alert ... particular, drug/device combinations. The current system received a score of 0 (range -10 to ... Innovation (iPCI) of Fairleigh Dickinson University’s ( FDU ) Rothman Institute of Innovation ...
    Breaking Biology Technology:BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3Brady Announces a New GHS Label Guide 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 2Third Medical Innovation Impact Index Issued by Fairleigh Dickinson University’s Initiative for Patient-Centered Innovation (iPCI) 3
    ... Informed Medical Communications,(IMC), one of the nation,s premier ... Saldarini to its Board of Directors. The,announcement was ... the company,s,headquarters in New York City. Mr. ... entrepreneurial,innovation in the area of healthcare services, most ...
    ... November 12 The Danish biotech cluster,known as ... into a global,hotspot in the field of personalized ... pharma and big biotech. Experience Danish,competencies at the ... 12th - 13th November. With over 10 ...
    ... Technology. Inc.,has been awarded a five-year contract with ... Inc. and the University HealthSystem,Consortium (UHC), two national ... The agreement makes Liftaem(TM) available to more than ... using proper equipment such,as Liftaem(TM), hospitals not only ...
    Cached Biology Technology:Informed Medical Communications Appoints Charles T. Saldarini to Board of Directors 2Danish Hotspot in Personalized Medicine 2Smart Medical Technology, Inc. Awarded Novation Contract for Ground-breaking Liftaem(TM) System that Aids Lifting and Transferring Patients 2
    (Date:6/26/2015)... , June 26, 2015 ATL Technology, LLC, ... devices with specialties in single use solutions, headquartered in ... MedConx, Inc. (a California corporation with ... San Jose, Costa Rica ). ... Costa Rica with ATL Technology,s existing facility in ...
    (Date:6/25/2015)... 25, 2015  TAKE Solutions Ltd., a global business ... United States Patent and Trademark Office (USPTO) for its ... TAKE Solutions, Clinical Accelerators to reduce the time taken ... to standardization without the accelerators), thus reducing time to ... At the heart of the patented Clinical Data ...
    (Date:6/24/2015)... 24, 2015  Synaptics Inc. (NASDAQ: SYNA ... today announced that Sharp has selected its industry-leading ... for its latest flagship smartphone device, the AQUOS ... million shipments of its fingerprint ID sensor technology, ... scalability and leadership in the biometrics market through ...
    Breaking Biology News(10 mins):ATL Technology Announces Acquisition of MedConx, Inc. and Expanded Global Footprint 2TAKE Solutions Awarded Patent By USPTO 2Synaptics Brings Natural ID Technology to Sharp's Newest Flagship Smartphone 2
    ... raises future hopes for human applications , Israeli scientists ... have successfully transplanted whole frozen and thawed ovaries in ... in the laboratory into early embryonic development. , Follow-up ... from which oocytes were recovered were still functioning normally ...
    ... College of Engineering researchers have discovered a new ... carbohydrates commonly found in plants. , Reporting in ... Steenbock Professor James Dumesic and colleagues detail a ... biomass-derived carbohydrates can be converted to sulfur-free liquid ...
    ... An infectious disease expert at Johns Hopkins who has ... known as Rocky Mountain spotted fever warns that the ... is a growing and dangerous sign of how humans ... boundaries. , In an article to be published in ...
    Cached Biology News:Israeli scientists successfully transplant frozen-thawed ovaries in sheep 2Israeli scientists successfully transplant frozen-thawed ovaries in sheep 3Green diesel: New process makes liquid transportation fuel from plants 2Infectious disease expert warns of spread of Rocky Mountain spotted fever 2Infectious disease expert warns of spread of Rocky Mountain spotted fever 3
    Porcine Aortic Smooth Muscle Cells (PAOSMC) (>500,000 cells)...
    ... IV Recognizes an epitope located ... β-tubulin isotype IV. No reactivity ... observed. ascites fluid synthetic peptide ... of β-tubulin isotype IV, conjugated ...
    Porcine Coronary Artery Smooth Muscle Cells (PCASMC) (>500,000 cells)...
    Porcine Aortic Endothelial Cells (PAOEC) (>500,000 cells)...
    Biology Products: